Related Experiment Video
Updated: Dec 18, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Published on: October 3, 2016
Who Should We Fear More: Biohackers, Disgruntled Postdocs, or Bad Governments? A Simple Risk Chain Model of Biorisk.
Anders Sandberg1, Cassidy Nelson1
1Anders Sandberg, PhD, is a Senior Research Fellow; Cassidy Nelson, MBBS, MPH, is a Research Scholar; both are at the Future of Humanity Institute, University of Oxford, Oxford, UK.
The study models biorisk, finding that highly powered actors are the likely perpetrators of biological attacks. However, fewer steps in the attack chain empower numerous low-resourced actors, increasing their risk.
Area of Science:
- Biosecurity
- Synthetic Biology
- Risk Assessment
Background:
- The evolving biological risk landscape is shaped by advancements in synthetic biology and biotechnology.
- The relative biosecurity threat posed by numerous low-resourced actors versus few high-powered actors remains unclear.
Purpose of the Study:
- To model biorisk to determine the likely source of a deliberate biological attack.
- To analyze the impact of actor power and the number of steps in a risk chain on biosecurity threats.
Main Methods:
- Introduction of a simple risk chain model for biorisk.
- Modeling actor success probability with a sigmoid distribution and actor power with a power-law distribution.
Main Results:
- Highly powered actors are the expected perpetrators of biorisk events, despite their lower numbers.
- As the number of steps in the risk chain decreases, lower-powered actors become more likely perpetrators.
- The most difficult step in the risk chain is the primary limiting factor for actors.
Conclusions:
- Biosecurity risk assessments must consider actor power distribution.
- Health security strengthening requires making steps leading to biological events more difficult to bypass.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
05:34Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
Published on: December 13, 2024
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Threats to Biodiversity
CRISPR
Steps in Outbreak Investigation
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...